Cancer Gene Therapy
Studies conducted at College of Medicine, Division of Medical Oncology on cancer gene therapy recently published
Published in Cancer Weekly, March 27th, 2007
Fresh data on cancer gene therapy are presented in the report "Recognizing and managing toxicities of molecular targeted therapies for colorectal cancer. Traditional therapeutic concepts and treatment regimens for colorectal cancer are currently changing with the demonstration of the efficacy of biologic agents in this disease setting. The addition of the anti-vascular endothelial growth factor (VEGF) monoclonal antibody bevacizumab (Avastin) to conventional chemotherapy in the first-and second-line settings has shown a survival benefit; this outcome has helped to rapidly change the standard of care," researchers in the United States report.
"Other targeted agents, such...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-03-27)
More Articles from Cancer Weekly
- Breast Cancer
FDA Approves Tykerb for Advanced Breast Cancer Patients - Cancer Vaccines
Mechanisms involved with tumor relapse identified - Breast Cancer
FDA Approves TYKERB (lapatinib) in Combination With Xeloda (capecitabine) for the Treatment of Advanced or Metastatic Breast Cancer in Women Who Have Progressed on Prior Therapy - Cancer
Aida Pharmaceuticals Initiates Preclinical Research of Potential Anti-Cancer Treatment Vasostatin-Apo2L - Cancer Gene Therapy
Oxxon Therapeutics to be Acquired by Oxford Biomedica - Cancer Vaccines
Integrated Biopharma's Proprietary Vaccine Technology Achieves Strong Positive Results - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
